The World Health Organization joined the US Centers for Disease Control in issuing HIV treatment guidelines that call for immediate anti-retroviral therapy when a patient's HIV test is positive. WHO also endorses widespread pre-exposure prophylaxis with the drugs, but notes there are controversies involved.
Researchers report high reinfection rates and attributable risk analysis suggest the existence of a subset of HIV-positive men who have sex with men with recurring sexual exposure to hepatitis C virus, which is troubling because HCV infections are more likely to become persistent and to lead to progressive liver disease in patients with HIV, including those on antiretroviral therapy.
About 50,000 people become infected with the human immunodeficiency virus (HIV) every year in the US, according to the Centers for Disease Control and Prevention (CDC). The latest data from the CDC offers valuable insight into current trends in HIV infection.
While any new research on the human immunodeficiency virus (HIV) is welcome, the majority has been focused on men. Researchers have found that the sexes feel pain differently, so the fact that gender-specific studies have been lacking for women only inhibits progress. However, the first trial of its kind used all women to assess the efficacy of an HIV medication.
National HIV/AIDS and Aging Awareness Day is observed every year on September 18, so in the midst of showing support for patients, a recent study pinpointed a natural defense against the human immunodeficiency virus (HIV) that may be a novel treatment in the future.
Researchers conducted an analysis of studies that spanned more than two decades and found that outbreaks of sexually transmitted hepatitis C is increasing among men who are HIV positive and have sex with other men.